Advice for States that Require Prior Prescriber Approval for Substitution

EP: 1.Comparing Biologics and Biosimilars

EP: 2.Biosimilar Utilization and Inventory Management

EP: 3.Operationalizing Biosimilars in Specialty Pharmacies

Now Viewing

EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution

EP: 5.Key Factors to Consider when Switching to Biosimilars

EP: 6.Pharmacy and Provider Collaboration

EP: 7.Biosimilar Copay Programs

Video content above is prompted by the following:

• How can pharmacists navigate states with stringent regulations on switching from biologics to biosimilars? For example, in Alabama, pharmacists cannot substitute an interchangeable biosimilar for the originator biologic without prior prescriber approval.